Cardiac safety in cluster headache patients using the very high dose of verapamil (≥720 mg/day)

Journal of Headache and Pain

Volumn 12, Issue 2, 2011, Pages 173-176

  Lanteri Minet, M ^a,b   Silhol, F ^c   Piano, V ^a   Donnet, A ^c  

^a PASTEUR HOSPITAL   (France)

^b INSERM   (France)

^c TIMONE HOSPITAL   (France)

Author keywords

Adverse events; Cluster headache; EKG monitoring; Verapamil

Indexed keywords

INDOMETACIN; OXYGEN; SUMATRIPTAN; TOPIRAMATE; VERAPAMIL; ZOLMITRIPTAN;

ADULT; AGED; ARTICLE; BRADYCARDIA; CARDIAC PATIENT; CLINICAL ARTICLE; CLUSTER HEADACHE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART ARRHYTHMIA; HUMAN; MALE; MULTICENTER STUDY; PATIENT ASSESSMENT; PRIORITY JOURNAL;

ADULT; ARRHYTHMIAS, CARDIAC; BRADYCARDIA; CLUSTER HEADACHE; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; VASODILATOR AGENTS; VERAPAMIL; YOUNG ADULT;

EID: 79958084475     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-010-0289-x     Document Type: Article

References (12)

1. Edlund W, Gronseth G, So Y, Franklin G (2004) Clinical practice guideline process manual. American Academy of Neurology, St. Paul, pp 1-57
2. Francis GJ, Becker WJ, Pringshiem TM (2010) Acute and preventive pharmacologic treatment of cluster headache. Neurology 75:463-473
3. May A, Leone M, Afra J et al (2006) EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol 13:1066-1077 (Pubitemid 44434311)
4. Bussone G, Leone M, Peccarisi C et al (1990) Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache 30:411-417 (Pubitemid 20376073)
5. Leone M, D'Amico D, Frediani F, Moschiano F, Grazzi L, Attanasio A (2000) Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo. Neurology 54:1382-1385 (Pubitemid 30174066)
6. Gabai IJ, Speirings ELH (1989) Prophylactic treatment of cluster headache with verapamil. Headache 29:167-168 (Pubitemid 20381933)
7. Tflelt-Hansen P, Tfelt-Hansen J (2008) Verapamil for cluster headache. Clinical pharmacology and possible mode of action. Headache 49:117-125
8. Luurtsema G, Molthoff CF, Windhorst AD et al (2003) (R)- and (S)[11C]verapamil as PET-tracers for measuring P-glycioprotein function: in vitro and in vivo evaluation. Nucl Med Biol 30:747-751 (Pubitemid 37123132)
9. Cohen AS, Matharu MS, Goadsby PJ (2007) Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy. Neurology 69:668-675 (Pubitemid 47256009)
10. Lanteri-Minet M, Autret A, Baudesson G et al (2005) French survey network on headaches and facial pains. In: Olesen J (ed) The classification and diagnosis of headache disorders. Oxford University Press, New York, pp 287-293
11. Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders, 2nd edn. Cephalalgia 24(Suppl 1):1-160
12. Beitelsheess AL, Gong Y, Wang D et al (2007) KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the International VErapamil SR/Trandolapril Study (INVSET). Pharmacogenetic Genomics 17:719-729 (Pubitemid 47263067)